🇺🇸
United States · US · US:0548-8352_8d3aa4dd-737c-49b4-af0d-fe95e3bee54d
Baqsimi
Orange BookUNIISPLATC H04AA01
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAmphastar Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeH04AA01
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1105488352022 TUBE in 1 CARTON (0548-8352-02) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE
Annotations
UNII (FDA Substance ID)
76LA80IG2G
GLUCAGON
RxCUI 4832
Orange Book
N210134
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "76LA80IG2G",
"rxcui": "4832",
"inchikey": null,
"display_name": "GLUCAGON",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "NASAL",
"spl_meta": {
"f1f5df9b-872f-44e5-a18f-f0b68e7e9254": {
"match": "brand_token",
"title": "BAQSIMI (GLUCAGON) POWDER [AMPHASTAR PHARMACEUTICALS, INC.]",
"spl_version": "6",
"published_date": "2025-08-11"
}
},
"productid": "0548-8352_8d3aa4dd-737c-49b4-af0d-fe95e3bee54d",
"productndc": "0548-8352",
"dosage_form": "POWDER",
"orange_book": {
"appl_no": "210134",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "3MG",
"product_no": "001",
"approval_date": "Jul 24, 2019"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "GLUCAGON",
"proprietary_name": "Baqsimi",
"active_ingred_unit": "mg/1",
"application_number": "NDA210134",
"marketing_category": "NDA",
"nonproprietary_name": "glucagon",
"start_marketing_date": "20190724",
"active_numerator_strength": "3"
}Related drugs
Other records sharing ATC code H04AA01.
Access this data programmatically
Query Baqsimi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.